Emergence of fluoroquinolone resistance in the native Campylobacter coli population of pigs exposed to enrofloxacin

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 5, 2004, Pages 872-874

  Delsol, Anne A ^a   Sunderland, Julie ^b   Woodward, Martin J ^c   Pumbwe, Lillian ^d   Piddock, Laura J V ^d   Roe, John M ^a  

^a Dept of Clinical Veterinary Science ^*  (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Animal models; C. coli; Quinolones

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENROFLOXACIN; ERYTHROMYCIN; ISOLEUCINE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; THREONINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CAMPYLOBACTER COLI; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DRUG EXPOSURE; DRUG FECES LEVEL; FECES ANALYSIS; GENE MUTATION; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; SAMPLING; SEQUENCE ANALYSIS; SWINE;

ANIMALS; ANTI-INFECTIVE AGENTS; CAMPYLOBACTER COLI; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FECES; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; QUINOLONES; SWINE;

EID: 2442685484     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh150     Document Type: Article

References (10)

1. Tauxe, R. V. (1992). Epidemiology of Campylobacter jejuni infections in the United States and other industrialised nations. In Campylobacter jejuni: Current Status and Future Trends (Nachamkin, I., Blaser, M. J. & Tompkins, L. S., Eds), p. 9. American Society for Microbiology, Washington DC, USA.
2. Goodman, L. J., Trenholme, G. M., Kaplan, R. L. et al. (1990). Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Archives of International Medicine 150, 541-6.
3. Frost, J. A. (2002). Drug resistance in Campylobacter jejuni and C. coli in England and Wales, 1993-2001. Paper published in the Surveillance for Antimicrobial Resistance in Domestic Livestock and the Risk to Public Health Proceedings, Coventry, Warwickshire. Department for Environmental, Food and Rural Affairs, London, UK.
4. Gibreel, A., Sjogren, E., Kaijser, B. et al. (1998). Rapid emergence of high level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrobial Agents and Chemotherapy 42, 3276-8.
5. Poole, K. (2000). Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrobial Agents and Chemotherapy 44, 2233-41.
6. Sunderland, J., Lovering, A. M., Tobin, C. M. et al. (2004). A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces. International Journal of Antimicrobial Agents, in press.
7. National Committee for Clinical Laboratory Standards. (1999). Performance Standards for Antimicrobial Susceptibility Testing - Ninth Informational Supplement: Approved Standard M100-S9. NCCLS, Wayne, PA, USA.
8. Eaves, D. J., Liebana, E., Woodward, M. J. et al. (2002). Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. Journal of Clinical Microbiology 40, 4121-5.
9. McDermott, P. F., Bodeis, S. M., English, L. L. et al. (2002). Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. Journal of Infectious Diseases 185, 837-40.
10. Luo, N., Sahin, O., Lin, J. et al. (2003). In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrobial Agents and Chemotherapy 47, 390-4.